Investigating modifiable pathways in psoriasis: A Mendelian randomization study
Journal of the American Academy of Dermatology · 2023-03 · 88 (3) · 593-601
DOI: 10.1016/j.jaad.2022.11.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2023-03. Verfasst von Christos V Chalitsios und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, Ioannina, Greece. Electronic address: christos.chalitsios@uoi.gr. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Psoriasis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: University of Ioannina.
Abstract (Originalsprache)
BACKGROUND: Potentially modifiable risk factors have previously been investigated only in conventional observational studies. OBJECTIVE: To assess whether genetically predicted exposures to modifiable factors are associated with the risk of psoriasis. METHODS: Two-sample Mendelian randomization (MR) analysis. RESULTS: An increased risk of psoriasis was noted for genetically predicted lifetime smoking index (odds ratio [OR]MR-IVW = 2.11; 95% confidence interval [CI], 1.28-3.51), childhood (OR MR-IVW = 1.40; 95% CI, 1.14-1.71) and adult body mass index (OR MR-IVW = 1.63; 95% CI, 1.32-2), waist (OR IVW = 1.86; 95% CI, 1.31-2.64), and hip circumference (OR MR-IVW = 1.55; 95% CI, 1.15-2.07). Protective association was also reported between genetically predicted longer sleep duration (OR MR-IVW = 0.56; 95% CI 0.37-0.84) and increased years of education (OR MR-IVW = 0.78; 95% CI, 0.62-0.98). This effect of education persisted in multivariable MR after adjusting for genetic predictors of smoking and adult body mass index (ORMVMR-IVW = 0.72; 95% CI, 0.56-0.92). LIMITATIONS: It was not possible to stratify for psoriasis severity. CONCLUSION: Smoking cessation and prevention of obesity are important strategies for decreasing the incidence of psoriasis. Similarly, targeting education inequality is expected to lead further to reductions in cases of psoriasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, Ioannina, Greece. Electronic address: christos.chalitsios@uoi.gr.
- Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, Ioannina, Greece.
- Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, Ioannina, Greece; Department of Biostatistics and Epidemiology, School of Public Health, Imperial College London, London, UK; Institute…
- Department of Biostatistics and Epidemiology, School of Public Health, Imperial College London, London, UK.
- Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, Ioannina, Greece; Department of Biostatistics and Epidemiology, School of Public Health, Imperial College London, London, UK.
Förderung
- University of Ioannina
Zitieren
APA
Chalitsios, C. V., Georgiou, A., Bouras, E., Evangelou, E., Gill, D., Tsilidis, K. K., & Tzoulaki, I. (2023). Investigating modifiable pathways in psoriasis: A Mendelian randomization study. Journal of the American Academy of Dermatology, 88(3), 593-601. https://doi.org/10.1016/j.jaad.2022.11.010
Vancouver
Chalitsios CV, Georgiou A, Bouras E, Evangelou E, Gill D, Tsilidis KK, et al. Investigating modifiable pathways in psoriasis: A Mendelian randomization study. Journal of the American Academy of Dermatology. 2023;88(3):593-601. doi:10.1016/j.jaad.2022.11.010
BibTeX
@article{Chalitsios2023,
author = {Chalitsios, Christos V and Georgiou, Andrea and Bouras, Emmanouil and Evangelou, Evangelos and Gill, Dipender and Tsilidis, Kostas K and Tzoulaki, Ioanna},
title = {Investigating modifiable pathways in psoriasis: A Mendelian randomization study},
journal = {Journal of the American Academy of Dermatology},
year = {2023},
volume = {88},
number = {3},
pages = {593--601},
doi = {10.1016/j.jaad.2022.11.010}
}
EUVIMED